Display options
Share it on

J Anaesthesiol Clin Pharmacol. 2016 Jan-Mar;32(1):84-8. doi: 10.4103/0970-9185.173334.

No difference in pain reduction after epidural steroid injections in diabetic versus nondiabetic patients: A retrospective cohort study.

Journal of anaesthesiology, clinical pharmacology

Francis Wong, Bahram Namdari, Suzanne Dupler, Mario Farias Kovac, Natalya Makarova, Jarrod E Dalton, Alparslan Turan

Affiliations

  1. Department of Anesthesiology, University of Washington, Seattle, Washington, USA.
  2. Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.
  3. Orthopedic and Rheumatology Institute, Cleveland Clinic, Cleveland, OH, USA.
  4. Department of Quantitative Health Sciences and Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.
  5. Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

PMID: 27006548 PMCID: PMC4784221 DOI: 10.4103/0970-9185.173334

Abstract

BACKGROUND AND AIMS: Diabetes affects peripheral and central neurons causing paresthesia, allodynia, hyperalgesia, and spontaneous pain. However, the effect of diabetes on response to epidural steroid injection (ESI) remains unknown. We hypothesized that diabetic patients receiving ESI will have different pain scores compared to nondiabetic patients. We tested a secondary hypothesis that pain reduction differs at different levels of hemoglobin A1c (HbA1c) for patients with diabetes.

MATERIAL AND METHODS: Data from 284 consecutive patients given ESIs for radiculopathy were obtained via a manual review of electronic medical records. We initially compared diabetic and nondiabetic groups with respect to balance on baseline demographic and morphometric characteristics. Next, a linear regression model was developed to evaluate the association between existing diabetes and postinjection reduction in pain scores. And finally, we univariably characterized the association between HbA1c and pain reduction.

RESULTS: After exclusion of nine patients, 275 patients were analysed, including 55 (20%) who were diabetic. Pain reduction after ESI was comparable in diabetic and nondiabetic patients (Wald test P = 0.61). The degree of pain reduction generally decreased with the level of HbA1c until reaching HbA1c levels of approximately 7.5%, after which point it stayed fairly constant.

CONCLUSION: There was no difference in pain reduction after ESIs comparing diabetic with nondiabetic patients; however, for diabetic patients, pain reduction may decrease with uncontrolled diabetes determined by high HbA1c values, thus suggesting pain physicians to take an active role in guiding their patients to have their blood glucose levels better regulated to improve outcomes of their ESIs.

Keywords: Diabetes mellitus; epidural; injections; pain

References

  1. Neurotherapeutics. 2009 Oct;6(4):638-47 - PubMed
  2. Reg Anesth Pain Med. 2012 Nov-Dec;37(6):595-600 - PubMed
  3. Pain Med. 2008 Sep;9(6):660-74 - PubMed
  4. Foot Ankle Int. 2013 Jan;34(1):85-90 - PubMed
  5. Int Rev Neurobiol. 2002;50:205-28 - PubMed
  6. Diabet Med. 2010 May;27(5):578-84 - PubMed
  7. Diabetologia. 2004 Aug;47(8):1343-53 - PubMed
  8. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):404-7 - PubMed
  9. N Engl J Med. 2014 Jul 3;371(1):11-21 - PubMed
  10. Pain Physician. 2014 May-Jun;17(3):247-53 - PubMed
  11. Stat Med. 2009 Nov 10;28(25):3083-107 - PubMed
  12. Spine (Phila Pa 1976). 1995 Jan 1;20(1):11-9 - PubMed

Publication Types

Grant support